What is ARDT (ARDT) stock price today?

ARDT (ARDT) is currently trading at $10.95, up 1.2% today.

What is ARDT P/E ratio?

ARDT's P/E ratio is 10.45. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ARDT return on equity (ROE)?

ARDT's return on equity (ROE) is 8.07%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is ARDT's market cap?

ARDT has a market capitalization of $1.57B.

NYSE · Medical - Care Facilities

ARDT (ARDT) Stock

$10.95 +1.20% NYSE: ARDT Healthcare

Valuation

Metric	Value
Price	$10.95
Market Cap	$1.57B
P/E Ratio	10.45
P/B Ratio	0.85
P/S Ratio	0.23
EPS (TTM)	$0.96
52-Week High	$15.48
52-Week Low	$7.71
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	8.07%
ROA	2.57%
ROCE	19.35%
Gross Margin	5.14%
Operating Margin	5.15%
Net Margin	2.09%
Debt/Equity	0.70
Current Ratio	1.97

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$4.9B	$5.1B	$5.4B	$6.0B	$6.3B
Operating Profit	$437.0M	$217.0M	$230.0M	$406.0M	$326.0M
Net Profit	$154.0M	$189.0M	$50.0M	$210.0M	$136.0M
EPS	$1.08	$1.32	$0.35	$1.58	$0.96
Op Margin	9.0%	4.2%	4.2%	6.8%	5.2%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	—	$4.9B	$5.1B	$5.0B	$5.3B
Total Liabilities	—	$3.8B	$4.0B	$3.4B	$3.6B
Cash	—	$456.0M	$438.0M	$557.0M	$710.0M
Borrowings	$0	$2.4B	$2.4B	$2.3B	$2.3B

Latest News

UnitedHealth to Top Second-Quarter Earnings Views on Favorable Utilization Trends, Morgan Stanley Says MT Newswires · Jun 30, 2026 Do Options Traders Know Something About Ardent Health Stock We Don't? Zacks · Jun 29, 2026 Is Ardent Health Stock a Buy After a Director Purchased More Than 11,000 Shares? Motley Fool · Jun 12, 2026 Spotlight On Undervalued Small Caps With Insider Activity In June 2026 Simply Wall St. · Jun 10, 2026 Will Ardent Health’s (ARDT) New CEO Shift the Focus of Its Post-IPO Efficiency Narrative? Simply Wall St. · Jun 7, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$147.0M	$-38.0M	$222.0M	$315.0M	$471.0M
Investing Cash Flow	$-275.0M	$-105.0M	$-275.0M	$-408.0M	$-426.0M
Financing Cash Flow	$-137.0M	$-79.0M	$-95.0M	$-79.0M	$-95.0M
Net Cash Flow	$-273.0M	$-262.0M	$-19.0M	$119.0M	$153.0M
Free Cash Flow	$8.0M	$-189.0M	$84.0M	$128.0M	$259.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	6.21
FCF Yield	14.71%
Quick Ratio	2.00
Interest Coverage	5.93
Return 1Y	-5.79%
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACHC	$28.25	+2.50%	-2.21	$2.63B	0.00%
ADUS	$114.67	+0.00%	17.77	$2.14B	0.00%
ASTH	$38.49	+0.99%	46.05	$1.91B	0.00%
AVAH	$13.46	+0.30%	5.98	$2.93B	0.00%
BKD	$11.93	+1.19%	-21.07	$2.85B	0.00%

About ARDT

ARDT is led by CEO Martin J. Bonick, employs 19,200 people, headquartered in US, publicly traded since 2024.

ARDT stock trades at $10.95 with a market capitalization of $1.57B. The stock is valued at a price-to-earnings (P/E) ratio of 10.45, price-to-book of 0.85, price-to-sales of 0.23. Over the past 52 weeks the stock has ranged between $7.71 and $15.48, and currently trades 29.3% below its 52-week high.

On profitability, ARDT generates a return on equity (ROE) of 8.07%, return on capital employed of 19.35%, an operating margin of 5.15%, a net profit margin of 2.09%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks NYSE High ROE Stocks All stock screens

Run Stock Screener Investing Guides